Clinical Trials Directory

Trials / Unknown

UnknownNCT05259579

ARMA for Postoperative GERD After Sleeve Gastrectomy

Anti-reflux Mucosal Ablation (ARMA) for the Treatment of Postoperative Gastroesophageal Reflux After Sleeve Gastrectomy - A Pilot Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This study is a pilot trial designed to evaluate the safety and efficacy of endoscopic anti-reflux ablation in postoperative gastroesophageal reflux after sleeve gastrectomy

Conditions

Interventions

TypeNameDescription
PROCEDUREAnti-reflux mucosal ablationMucosal ablation is planned around the cardia on the gastric side in a butterfly shape. Submucosal layer is raised by injecting saline with indigo carmine dye. Mucosal ablation is performed using the triangle-tip knife in spray coagulation mode.

Timeline

Start date
2022-02-01
Primary completion
2023-01-31
Completion
2023-07-31
First posted
2022-02-28
Last updated
2022-02-28

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT05259579. Inclusion in this directory is not an endorsement.

ARMA for Postoperative GERD After Sleeve Gastrectomy (NCT05259579) · Clinical Trials Directory